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Abstract
Background: In 2002 the Australian National Competitive Grants System was opened to the
Institute of Advanced Studies at the Australian National University as part of a commitment to
transparency, competitiveness, and collaboration in national research funding.
Results: The block grant to the John Curtin School of Medical Research had progressively eroded
over many years. Access to the National Competitive Grants Schemes and associated
infrastructure (through an agreed 'buy-in' price of 20% of block funding) has succeeded in its aims
and in reversing this progressive effective decrease in funding.
Conclusion: Access to the National Competitive Grant Scheme has allowed the John Curtin
School of Medical Research to contribute more broadly to Australia's health and medical research
effort through increased collaboration, in a transparent and competitive funding environment.
Discussion
Australia has developed a unique blend of medical
research institutions, from universities, teaching hospi-
tals, independent medical research institutes to a range of
smaller centres. Universities with medical schools have
been the primary forces in medical research and many of
the university teaching hospitals fostered the develop-
ment of research institutes within their grounds [1]. The
spectacular development of medical research in Australia
over the last 50 years was reviewed recently in recognition
of Australia's Centenary of Federation celebrations [2].
The Australian National University (ANU) was estab-
lished as a research university [1] with four founding
schools. The John Curtin School of Medical Research
(JCSMR) was funded for its first 50 years through a one-
line Commonwealth Grant to the ANU. Although the
School had always sought external funds (its first grant
was £1500 to Frank Fenner from the Rural Credits Devel-
opment Fund in 1952), it was ineligible for National
Health and Medical Research Council (NHMRC), Austral-
ian Research Council (ARC) and other national competi-
tive grants. The School unquestionably benefited from
generous (by local standards) funding in its early years
and its science profited accordingly. Fundamental discov-
eries have included Nobel Prize winning work on the elu-
cidation of mechanisms of transmission of signals in the
nervous system (Eccles) and the discovery of the role of
the major histocompatibility complex (Doherty and Zink-
ernagel). Today, the School has a wide range of research in
such areas as infection, neurosciences, genomics and
molecular bioscience, and has spawned a major national
research facility, the Australian Phenomics Facility. Some
key discoveries in recent years are summarised in Table 1.
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It can be argued that JCSMR's position as one of the orig-
inal block-funded research schools of the Institute of
Advances Studies (IAS) has given it the opportunity to
pursue long-term, independent medical research. Many
staff and alumni of JCSMR, including its present Director,
argue that the Nobel Prizes, the Albert Einstein World
Award, the Japan Prize, the Copley Medal, and a host of
other international awards attest to the success of this
funding strategy over the past 50 years, and that the scien-
tific achievements that those prizes signify could only
have been made by research that could be conducted over
long (10 to 20 year) time frames.
But the funding climate has changed dramatically over the
last few decades. Twenty five years ago many tenured Aus-
tralian university or teaching hospital staff were able to
undertake research even without external funding. Infra-
structure was relatively generous, there was still funding
for university technical research staff, hospitals provided
drugs and consumables and even beds at no cost to the
researcher, and research activities merged relatively seam-
lessly into those of teaching and patient care. Today
research is increasingly separated from teaching and care,
and the days of in-kind support are long gone. Research is
an investment for the nation and the future, but in con-
temporary funding climates within universities and hos-
pitals it is increasingly becoming an optional extra,
undertaken only when researchers are able to attract suffi-
cient external resources.
The change in environment and the disappearance of
cross subsidisation from patient care and/or teaching has
both advantages and disadvantages. Today's research (and
research funding) is more transparent: what is spent on
research as opposed to care and teaching, at least at the
micro level, is much better defined. And, in parallel, the
loss of capacity to undertake research that is not peer
reviewed has almost certainly raised research standards.
The negatives are equally obvious. The University of Mel-
bourne submission to the Wills review stated 'The danger
is that if the importance of the nexus between research
and learning is not visible to tertiary students because
University research is allowed to run down through poor
infrastructure, equipment or lack of opportunity of
research scientists then research institutes and teaching
hospitals will inevitably suffer from a lack of quality of
graduates available to them'[3].
The JCSMR has not been exempted from these pressures,
and over the last 20 years the value of the block grant has
been progressively eroded. The JCSMR grant was a one-
line grant to the Director, which provided flexibility, but
inhibited collaboration because of restrictive rules around
the National Competitive Grants Scheme. Accordingly, a
Table 1: Recent Research Achievements, John Curtin School of Medical Research
Year Achievement Researchers(s) Comment Reference
1999 Heparanase cloned Hulett, Freeman and 
colleagues
Inhibiting the enzyme is the 
basis of cancer treatments 
based on sulfated 
polysaccharides
Nature Medicine 5:803-
809, 1999
2001 First diabetes susceptibility 
gene identified
Slattery and colleagues Serendipitous discovery 
providing a potential 
therapeutic target in type 1 
diabetes
Proc Nat Acad Sci, USA 
98:11533-11538, 2001
2002 Amiloride derivatives block 
ion channel activity and 
enhancement of virus-like 
particle budding caused by 
an HIV-1 protein
Gage and colleagues Research on compounds 
that block viral ion 
channels raises the 
possibility of inhibiting 
viruses that utilize ion 
channels
Eur. Biophys. J. 31:26-35, 
2002
2002 Antibody 'tail sequence' 
identified that has 
significant implications for 
immunological memory
Martin and Goodnow Finding has wide 
implications for 
vaccination, allergy and 
autoimmunity
Nature Immunology 3:182-
188, 2002
2002 Phase II clinical trials of PI 
88 anti-cancer drug
Parish and colleagues Promising results in 
treating advanced 
melanoma
Eur. J Cancer 38(S7):74, 
2002
2003 New approach to 
vaccination against cancer
Parish Approach is potentially less 
susceptible to immune 
evasion
Immunology and Cell 
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desire for transparency, competitiveness and
collaboration led to a decision in 2000 by the Common-
wealth Government that the IAS of the ANU could enter
the National Competitive Grants Scheme. The negotia-
tions that led to partial entry of JCSMR into the NHMRC
schemes in 2001 (for 2002) were long and complex. How-
ever the negotiations between JCSMR and NHMRC were
paralleled by those between the ARC and ANU and led to
a jointly agreed 'buy in' price of 20% of 2000 funding for
the IAS to gain access to the various national funding,
research training and related schemes. This was $1.7 mil-
lion per annum for JCSMR access to the National Compet-
itive Grant Schemes and a similar amount for access to the
training and infrastructure schemes. It was determined
initially that entry would be phased, but after one year the
ARC determined that the phase-in was unnecessary and
gave the IAS full entry from 2002 (for 2003), and the
NHMRC followed suit.
The JCSMR felt that, at last, it was able to redress the com-
petitive disadvantage the School faced because of its
essentially fixed funding over the last 10 to 15 years, at a
time when government funding for the NHMRC system
had doubled and then redoubled, from around $65 mil-
lion in the late eighties to $176 million in 1999 to $381
million in 2004. The rest of the system waited, not with-
out apprehension, for the outcome, but there had long
been a wish within the research community that JCSMR
be subject to the same forms of peer review as the broader
medical research community.
Removing barriers to collaboration, the outcome of these
changes, is important for 21st  century approaches to
improving health. The World Health Organisation has
stated that the likely trends in global health in the 21st cen-
tury include widespread absolute and relative poverty,
demographic changes, ageing, growth of cities, epidemio-
logical changes, continuing high influence of infectious
diseases, increasing incidence of non-communicable dis-
eases, injuries and violence, global environmental threats
to human survival, new technologies, information and
telemedicine services, advances in biotechnology, evolv-
ing partnerships for health that include private and public
sectors and civil society, and globalisation of trade, travel
and the spread of values and ideas. Research to deal with
global health problems will therefore necessarily be
multidisciplinary, involving biomedical, clinical, public
health and health services research, and include the social
sciences, information sciences and engineering, physics,
chemistry, ecology and environmental sciences and eco-
nomics. As part of the IAS, the JCSMR is accordingly
strongly positioned. Not that this need for a multidiscipli-
nary approach is really a new concept – in 1902 Osler
stated that the remit of medical research was 'to wrest
from nature the secrets which have perplexed philoso-
phers in all ages, to trace to their sources the causes of dis-
ease, to correlate the vast stores of knowledge, that they
may be quickly available for the prevention and the cure
of disease – these are our ambitions' [4].
In the first three years that JCSMR has been eligible to
apply for research funding, their researchers have been
awarded a total of $18 million (88% NHMRC, 12% ARC)
in competitive funding for periods of up to five years. All
three NHMRC program grants held by researchers at the
JCSMR are collaborative with other Australian institutions
and School researchers hold four ARC linkage grants. This
collaboration bodes well for Australian health and for
biotechnology growth. In a highly competitive world,
Australian researchers need every opportunity to succeed.
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